相关实验视频
Updated: Jan 17, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
对于C1q脏病的C1q脏病治疗引起的肝结核病与最小变化的疾病:一个病例报告
Huifang Wang1, Yiqi Huang2, Feng Jin2
1Department of Digestive System, Shaoxing Second Hospital, Shaoxing, Zhejiang, Zhejiang, China.
Frontiers in medicine
|September 15, 2025
概括
利图西马布有效治疗C1q脏病与最小变化疾病 (MCD). 然而,这种B细胞消耗疗法具有罕见的严重感染风险,如肝结核病,特别是在老年患者中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 利图西马布是一种用于自身免疫性病的B细胞消耗疗法.
- 虽然有效,但Rituximab治疗可能会增加感染的风险.
- 结核病是一种罕见但严重的Rituximab治疗的潜在并发症.
研究的目的:
- 报告患有C1q脏病和最小变化疾病 (MCD) 的患者肝结核病的病例,用Rituximab治疗.
- 为了强调在利图西马布治疗期间对罕见感染的警的重要性.
主要方法:
- 一个81岁的男性患者的病例介绍,患有C1q脏病和MCD.
- 这位患者因脏病而接受了利图西马布.
- 肝结核的诊断通过肝活检证实,在发烧和肝脏质量出现后.
主要成果:
- 利图西马布治疗最初缓解了C1q脏病和MCD患者的蛋白尿症.
- 患者在接收第二剂瑞图西马布后发展出肝结核病.
- 抗结核治疗导致发烧,腹痛和肝脏病变的消失.
结论:
- 利图西马布可能是MCD的C1q脏病的可行的治疗方法.
- 医疗保健提供者必须对接受rituximab的患者,特别是老年人的肺结核等罕见感染保持警.
- 在Rituximab治疗之前,建议老年患者进行潜在结核病的常规查.
相关概念视频
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis I
844
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
844
Pulmonary Tuberculosis III
941
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
941
Pulmonary Tuberculosis IV
479
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
479
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K

